Valvular heart disease with the use of fenfluramine-phentermine

Texas Heart Institute Journal

Volumn 38, Issue 5, 2011, Pages 581-583

  Surapaneni, Phani ^a   Vinales, Karyne L ^a   Najib, Mohammad Q ^a   Chaliki, Hari P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aortic valve insufficiency chemically induced; Appetite depressants adverse effects; Fenfluramine adverse effects; Heart valve diseases chemically induced complications pathology; Hypertension; Mitral valve insufficiency chemically induced; Obesity complications; Phentermine adverse effects; Pulmonary chemically induced; Treatment outcome; Tricuspid valve insufficiency chemically induced

Indexed keywords

ATORVASTATIN; DULOXETINE; FENFLURAMINE; HYDROCHLOROTHIAZIDE; OXYBUTYNIN; PHENTERMINE; TRAZODONE; ZOLPIDEM;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT DISORDER; CASE REPORT; CENTRAL NERVOUS SYSTEM; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART MURMUR; HUMAN; MEDICAL HISTORY; MITRAL VALVE REGURGITATION; MORBID OBESITY; PHYSICAL EXAMINATION; PREVALENCE; PULMONARY HYPERTENSION; STOMACH BYPASS; SYSTOLIC HEART MURMUR; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE;

ANTI-OBESITY AGENTS; DRUG COMBINATIONS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FENFLURAMINE; GASTRIC BYPASS; HEART VALVE DISEASES; HEART VALVES; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; OBESITY; PHENTERMINE;

EID: 83455199949     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluramine-phentermine [published erratum appears in N Engl J Med 1997;337(24):17-83
2. N Engl J Med 1997;337(9):581-8.
3. Khan MA, Herzog CA, St Peter JV, Hartley GG, Madlon- Kay R, Dick CD, et al. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med 1998;339(11):713-8.
4. Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 1993;87(4):1188-96.
5. Mast ST, Jollis JG, Ryan T, Anstrom KJ, Crary JL. The progression of fenfluramine-associated valvular heart disease assessed by echocardiography. Ann Intern Med 2001;134(4): 261-6.
6. Brenot F, Herve P, Petitpretz P, Parent F, Duroux P, Simonneau G. Primary pulmonary hypertension and fenfluramine use. Br Heart J 1993;70(6):537-41.